Supriya Lifescience informs about press release

25 Jan 2025 Evaluate
Supriya Lifescience has informed that the Board of Directors of the Company at their Meeting held on January 24, 2025 has considered and approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2024. The company has attached the Press Release with regard to the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

721.10 0.30 (0.04%)
01-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1742.70
Dr. Reddys Lab 1205.30
Cipla 1437.85
Lupin 2055.15
Zydus Lifesciences 973.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on